Merz North America and Foamix to Develop an Innovative Medicated Foam

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

GREENSBORO, N.C. & REHOVOT, Israel--(BUSINESS WIRE)--Merz North America, Inc. and Foamix Ltd., today announced that they have established a collaboration to develop and commercialize an innovative medicated topical foam. The parties have executed a development agreement and a memorandum of understanding (MOU) granting Merz an exclusive worldwide license for the global development and commercialization of the product.

Help employers find you! Check out all the jobs and post your resume.

Back to news